Amedeo Smart

Free Medical Literature Service

 

Amedeo

Colorectal Neoplasms
  Free Subscription

Articles published in
Oncology
    July 2024
  1. ERCIYESTEPE M, Selvi O, Dinc G, Ozturk AE, et al
    Factors affecting recurrence and survival in Stage IIA colon cancer patients.
    Oncology. 2024 Jul 15. doi: 10.1159/000540334.
    >> Share

    June 2024
  2. ALKAN A, Doganer GI, Tanriverdi O
    Serum Uric Acid Level May Be A Predictive Factor For BRAF V600E Mutation In Older Patients With Metastatic Colorectal Cancer: An Exploratory Analysis.
    Oncology. 2024 Jun 27. doi: 10.1159/000539981.
    >> Share

    February 2024
  3. NUMATA K, Shiozawa M, Ono Y, Iguchi K, et al
    Clinical significance of the post/preoperative anti-p53 antibody ratio in predicting the prognosis of patients with colorectal cancer after curative surgery and its usefulness in combination with carcinoembryonic antigen.
    Oncology. 2024 Feb 21. doi: 10.1159/000537963.
    >> Share

    January 2024
  4. TOQUERO P, Mondejar R, Romero-Laorden N, Mendez E, et al
    Is older age an independent prognostic factor of survival in metastatic colorectal cancer?
    Oncology. 2024 Jan 17. doi: 10.1159/000535187.
    >> Share

  5. MIYAGAWA Y, Kitazawa M, Tokumaru S, Nakamura S, et al
    Impact of Oophorectomy on Survival and Improving Nutritional Status in Ovarian Metastasis from Colorectal Adenocarcinoma.
    Oncology. 2024;102:114-121.
    >> Share

  6. VIVALDI C, Genovesi V, Ugolini C, Bernardini L, et al
    Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology.
    Oncology. 2024;102:157-167.
    >> Share

  7. JATHO A, Myung SK, Kim J, Han SS, et al
    Consumption of Sugar-Sweetened Soft Drinks and Risk of Gastrointestinal Cancer: A Systematic Review and Meta-Analysis of Observational Studies.
    Oncology. 2024;102:141-156.
    >> Share

  8. MATSUNAKA T, Goi T, Kurebayashi H, Morikawa M, et al
    18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging-Defined Extramural Venous Invasion Predicts Distant Metastasis and Reflects Strong Tumor Invasiveness in Rectal Cancer.
    Oncology. 2024;102:99-106.
    >> Share

  9. WU HQ, Li J, Miao JD, Li JW, et al
    Is Total Neoadjuvant Treatment Beneficial for Locally Advanced Rectal Cancer? A Meta-Analysis of Randomized Controlled Trials.
    Oncology. 2024;102:399-413.
    >> Share

  10. ROMERO ZOGHBI SE, Martin Martin M, Garcia JC, Valero M, et al
    Total Neoadjuvant Therapy Approach for the Treatment of Locally Advanced Rectal Cancer: Where Do We Stand?
    Oncology. 2024;102:646-658.
    >> Share

    December 2023
  11. MIAO R, Kim DW, Yu J, Malafa M, et al
    RNA Expression-based Analysis to Predict Response in Patients with Metastatic Mismatch Repair Proficient Colorectal Cancer Treated with Regorafenib and Nivolumab.
    Oncology. 2023 Dec 7. doi: 10.1159/000535599.
    >> Share

    November 2023
  12. ZHU C, Ji D, Ma J, Da M, et al
    Association between artificial sweeteners-aspartame consumption and colorectal cancer risk: evidence-based strategies.
    Oncology. 2023 Nov 2. doi: 10.1159/000534812.
    >> Share

    October 2023
  13. UROOG L, Rahmani AH, Alsahli MA, Almatroodi SA, et al
    Genetic profile of FOXO3 Single Nucleotide Polymorphism in colorectal cancer patients.
    Oncology. 2023 Oct 19. doi: 10.1159/000533729.
    >> Share

    September 2023
  14. PREJAC J, Omrcen T, Radic J, Vrdoljak E, et al
    Predicting Trifluridine/Tipiracil Treatment Outcomes in Refractory Metastatic Colorectal Cancer Patients: A Multicenter Exploratory Analysis.
    Oncology. 2023 Sep 12. doi: 10.1159/000533567.
    >> Share

  15. DOLESCHAL B, Niedersuss-Beke D, Kirchweger P, Petzer A, et al
    Survival outcome in early onset metastatic colorectal cancer: a multicenter matched-pair analysis.
    Oncology. 2023 Sep 12. doi: 10.1159/000533429.
    >> Share

    June 2023
  16. BARDAKCI M, Demirtas Esmer D, Hafizoglu E, Yaslikaya S, et al
    Comparison of the efficacy and safety of 3 months of CAPOX followed by 3 months of capecitabine and 6 months of CAPOX/FOLFOX in the adjuvant treatment of low-risk stage-III colon cancer treated surgically.
    Oncology. 2023 Jun 28. doi: 10.1159/000531722.
    >> Share

  17. GIANNOPOULOU N, Constantinou C
    Recent developments in diagnostic and prognostic biomarkers for colorectal cancer: a narrative review.
    Oncology. 2023 Jun 26. doi: 10.1159/000531474.
    >> Share

    March 2023
  18. MAUREL JM, Tamayo MB, Pitargue R, Ong-Cornel AB, et al
    Practical notes on the current ESMO consensus guidelines for the management of patients with metastatic colorectal cancer in resource-constrained environments of low- to middle-income countries.
    Oncology. 2023 Mar 23. doi: 10.1159/000530275.
    >> Share

    January 2023
  19. SUZUKI T, Sadahiro S, Okada K, Miyakita H, et al
    Clinical T2N0 Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy plus Local Excision.
    Oncology. 2023;101:166-172.
    >> Share

  20. DRAPER A, Jung EH, Cao Y, Atallah RP, et al
    The Impact of Poorly Differentiated Histology on Immunotherapy in Advanced Gastrointestinal Cancers.
    Oncology. 2023;101:213-223.
    >> Share

  21. DUQUE-SANTANA V, Lopez-Campos F, Martin-Martin M, Valero M, et al
    Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer.
    Oncology. 2023;101:349-357.
    >> Share

    October 2022
  22. OKAMOTO K, Nozawa H, Emoto S, Murono K, et al
    Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer.
    Oncology. 2022 Oct 17:1-7. doi: 10.1159/000527012.
    >> Share

  23. KIM TW, Hwang SW, Kim KO, Cha JM, et al
    The prognostic utilities of DNA mismatch repair status and KRAS and BRAF mutation in Korean colorectal cancer patients: The KASID multicenter study.
    Oncology. 2022 Oct 3. pii: 000527285. doi: 10.1159/000527285.
    >> Share

    September 2022
  24. SAWAI K, Goi T, Sakamoto S, Matsunaka T, et al
    Oxidative stress as a biomarker for predicting the prognosis of patients with colorectal cancer.
    Oncology. 2022 Sep 16. pii: 000527032. doi: 10.1159/000527032.
    >> Share

    July 2022
  25. HUANG CY, Pai YC, Yu LC
    Glucose conferred irinotecan chemoresistance through divergent actions of pyruvate and ATP in cell death and proliferation of colorectal cancer.
    Oncology. 2022 Jul 18. pii: 000525977. doi: 10.1159/000525977.
    >> Share

    January 2022
  26. TAIRA T, Nozawa H, Kawai K, Sasaki K, et al
    Prognoses in Pathologically Confirmed T1 Lower Rectal Cancer Patients with or without Preoperative Therapy: An Analysis Using the Surveillance, Epidemiology, and End Results Database.
    Oncology. 2022;100:82-88.
    >> Share

  27. SETO S, Tsujikawa T, Sawai K, Kurebayashi H, et al
    Feasibility of [18F]FDG PET/MRI with Early-Delayed and Extended PET as One-Stop Imaging for Staging and Predicting Metastasis in Rectal Cancer.
    Oncology. 2022;100:212-220.
    >> Share

    November 2021
  28. BJORKMAN K, Kaprio T, Beilmann-Lehtonen I, Stenman UH, et al
    TATI, TAT-2, and CRP as Prognostic Factors in Colorectal Cancer.
    Oncology. 2021 Nov 18:1-9. doi: 10.1159/000518956.
    >> Share

    October 2021
  29. WEIN A, Stoehr R, Kersting S, Siebler J, et al
    A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the I
    Oncology. 2021 Oct 20:1-11. doi: 10.1159/000519252.
    >> Share

    January 2021
  30. REIJONEN P, Peltonen R, Tervahartiala T, Sorsa T, et al
    Serum Matrix Metalloproteinase-8 and Myeloperoxidase Predict Survival after Resection of Colorectal Liver Metastases.
    Oncology. 2021;99:766-779.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016